Ibrahim Nassour, MD, MSCS - Research

Research at a glance

Top areas of exploration

Pancreatic Neoplasms , 23 publications
Adenocarcinoma , 17 publications
Robotic Surgical Procedures , 12 publications
Pancreaticoduodenectomy , 12 publications

Research activity

92 publications

1,539 citations

Why is this important?

Active clinical trials

Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer

This phase III trial compares perioperative chemotherapy (given before and after surgery) versus adjuvant chemotherapy (given after surgery) for the treatment of pancreatic cancer that can be removed by surgery (removable/resectable). Chemotherapy鈥�

Investigator: Ibrahim Nassour
Status: Accepting Candidates
Ages: 18 Years - N/A
Sexes: All

My publications

92 publications

2023

Prognosis and Treatment Outcomes of Bone Metastasis in Gallbladder Adenocarcinoma: A SEER-Based Study

Cancers

鈥�

2023

Robotic Pancreaticoduodenectomy: Increased Adoption and Improved Outcomes: Is Laparoscopy Still Justified?

Annals of surgery

鈥�

2023

The risk of clinically-relevant pancreatic fistula after pancreaticoduodenectomy is better predicted by a postoperative trend in drain fluid amylase compared to day 1 values in isolation.

Surgery

鈥�

2023

The use of angiotensin system inhibitors correlates with longer survival in resected pancreatic adenocarcinoma patients.

HPB : the official journal of the International Hepato Pancreato Biliary Association

鈥�

2022

Adaptive Dynamic Therapy and Survivorship for Operable Pancreatic Cancer.

JAMA network open

鈥�

网红黑料

Ibrahim Nassour, MD, MSCS : Research

Research at a glance

Top areas of exploration

Research activity

Active clinical trials

My publications

Prognosis and Treatment Outcomes of Bone Metastasis in Gallbladder Adenocarcinoma: A SEER-Based Study

Robotic Pancreaticoduodenectomy: Increased Adoption and Improved Outcomes: Is Laparoscopy Still Justified?

The risk of clinically-relevant pancreatic fistula after pancreaticoduodenectomy is better predicted by a postoperative trend in drain fluid amylase compared to day 1 values in isolation.

The use of angiotensin system inhibitors correlates with longer survival in resected pancreatic adenocarcinoma patients.

Adaptive Dynamic Therapy and Survivorship for Operable Pancreatic Cancer.

网红黑料

Research at a glance

Top areas of exploration

Research activity

Active clinical trials

My publications

Filter publications

Prognosis and Treatment Outcomes of Bone Metastasis in Gallbladder Adenocarcinoma: A SEER-Based Study

Robotic Pancreaticoduodenectomy: Increased Adoption and Improved Outcomes: Is Laparoscopy Still Justified?

The risk of clinically-relevant pancreatic fistula after pancreaticoduodenectomy is better predicted by a postoperative trend in drain fluid amylase compared to day 1 values in isolation.

The use of angiotensin system inhibitors correlates with longer survival in resected pancreatic adenocarcinoma patients.

Adaptive Dynamic Therapy and Survivorship for Operable Pancreatic Cancer.